Plasma leptin and adiposity during antipsychotic treatment of schizophrenia (Q45059332)

9 December 2017

Plasma leptin and adiposity during antipsychotic treatment of schizophrenia (English)

1 reference

9 December 2017

0 references

Dan W Haupt

1

1 reference

9 December 2017

Angela Luber

2

1 reference

9 December 2017

Justin Maeda

3

1 reference

9 December 2017

Angela K Melson

4

1 reference

9 December 2017

Julie A Schweiger

5

1 reference

9 December 2017

John W Newcomer

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

9 December 2017

Neuropsychopharmacology

1 reference

9 December 2017

30

1 reference

9 December 2017

1

1 reference

9 December 2017

184-191

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300563

9 December 2017

0 references

cites work

Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Leptin sensitive neurons in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Increased obese mRNA expression in omental fat cells from massively obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Activation of central melanocortin pathways by fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Effects of long-term treatment with antipsychotics on serum leptin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

AGA technical review on obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Low leptin levels but normal body mass indices in patients with depression or schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Leptin: a review of its peripheral actions and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

The perils of portliness: causes and consequences of visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Brain histamine and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Mortality and causes of death in first admitted schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Glucose-induced increase in memory performance in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Vagal stimulation rapidly increases leptin secretion in human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Report of the expert committee on the diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

The physiology of cellular liporegulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Leptin secretion from subcutaneous and visceral adipose tissue in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Serum leptin levels increase rapidly after initiation of clozapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

Biomarkers of satiation and satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Adrenomedullary function and its regulation in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Adipose tissue leptin production and plasma leptin kinetics in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Is visceral adiposity the "enemy within"?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300563

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300563

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference